☰

Patrick L. McGeer, MD, University of British Columbia 1958,PhD,Princeton 1951, OC, OBC, FRSC, FRCP(C) - Publications

Affiliations: 
Medicine University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=19
Website:
http://en.wikipedia.org/wiki/Pat_McGeer
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

243 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wu J, Guo J, Du X, Mcgeer PL. Anti-inflammatory and neuroprotective effects of kissoone B and extracts of Valeriana amurensis Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy. 30: 474-481. DOI: 10.1007/S43450-020-00037-1  0.303
2018 Sabbagh MN, Shi J, Lee M, Arnold L, Al-Hasan Y, Heim J, McGeer P. Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings. Bmc Neurology. 18: 155. PMID 30257642 DOI: 10.1186/S12883-018-1160-Y  0.333
2018 McGeer PL, McGeer E. Conquering Alzheimer's Disease by Self Treatment. Journal of Alzheimer's Disease : Jad. PMID 29562519 DOI: 10.3233/Jad-179913  0.359
2017 McGeer PL, Guo JP, Lee M, Kennedy K, McGeer EG. Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs. Journal of Alzheimer's Disease : Jad. PMID 29103042 DOI: 10.3233/Jad-170706  0.371
2017 De Lorenzi E, Chiari M, Colombo R, Cretich M, Sola L, Vanna R, Gagni P, Bisceglia F, Morasso C, Lin JS, Lee M, McGeer PL, Barron AE. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly. Journal of Alzheimer's Disease : Jad. PMID 28731438 DOI: 10.3233/Jad-170223  0.316
2017 Sabbagh MN, Shi J, Arnold L, McGeer P. [P2-255]: SALIVARY AMYLOID-BETA PROTEIN LEVELS CAN DIAGNOSE ALZHEIMER DISEASE AND PREDICT ITS FUTURE ONSET Alzheimer's & Dementia. 13: P710-P711. DOI: 10.1016/J.Jalz.2017.06.907  0.313
2016 McGeer PL, Lee M, McGeer EG. A review of human diseases caused or exacerbated by aberrant complement activation. Neurobiology of Aging. 52: 12-22. PMID 28104543 DOI: 10.1016/J.Neurobiolaging.2016.12.017  0.313
2016 Lee M, Guo JP, Kennedy K, McGeer EG, McGeer PL. A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels. Journal of Alzheimer's Disease : Jad. PMID 27792013 DOI: 10.3233/Jad-160748  0.357
2016 McGeer PL, Rogers J, McGeer EG. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years. Journal of Alzheimer's Disease : Jad. 54: 853-857. PMID 27716676 DOI: 10.3233/Jad-160488  0.39
2016 Lee M, McGeer EG, McGeer PL. Quercetin, not caffeine, is a major neuroprotective component in coffee. Neurobiology of Aging. 46: 113-123. PMID 27479153 DOI: 10.1016/J.Neurobiolaging.2016.06.015  0.365
2016 Lee M, McGeer EG, McGeer PL. Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases. Journal of Neuroinflammation. 13: 32. PMID 26856696 DOI: 10.1186/S12974-016-0488-8  0.311
2015 Lee M, Wathier M, Love JA, McGeer E, McGeer PL. Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid. Neurobiology of Aging. PMID 26248865 DOI: 10.1016/J.Neurobiolaging.2015.06.018  0.327
2015 Zhu A, Wu Z, Meng J, McGeer PL, Zhu Y, Nakanishi H, Wu S. The Neuroprotective Effects of Ratanasampil on Oxidative Stress-Mediated Neuronal Damage in Human Neuronal SH-SY5Y Cells. Oxidative Medicine and Cellular Longevity. 2015: 792342. PMID 26064424 DOI: 10.1155/2015/792342  0.317
2015 O'Hare E, Jeggo R, Kim EM, Barbour B, Walczak JS, Palmer P, Lyons T, Page D, Hanna D, Meara JR, Spanswick D, Guo JP, McGeer EG, McGeer PL, Hobson P. Lack of support for bexarotene as a treatment for Alzheimer's disease. Neuropharmacology. PMID 26025659 DOI: 10.1016/J.Neuropharm.2015.04.020  0.349
2015 Hashioka S, McGeer EG, Miyaoka T, Wake R, Horiguchi J, McGeer PL. Interferon-γ-induced neurotoxicity of human astrocytes. Cns & Neurological Disorders Drug Targets. 14: 251-6. PMID 25687700 DOI: 10.2174/1871527314666150217122305  0.375
2015 Lee M, Shi X, Barron AE, McGeer E, McGeer PL. Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation. Biochemical Pharmacology. 94: 130-41. PMID 25686659 DOI: 10.1016/J.Bcp.2015.02.003  0.355
2015 McGeer PL, McGeer EG. Targeting microglia for the treatment of Alzheimer's disease. Expert Opinion On Therapeutic Targets. 19: 497-506. PMID 25435348 DOI: 10.1517/14728222.2014.988707  0.361
2015 Lee M, McGeer E, McGeer PL. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis. Neurobiology of Aging. 36: 42-52. PMID 25169677 DOI: 10.1016/J.Neurobiolaging.2014.07.024  0.384
2013 McGeer PL, McGeer EG. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathologica. 126: 479-97. PMID 24052108 DOI: 10.1007/S00401-013-1177-7  0.393
2013 Jantaratnotai N, Ling A, Cheng J, Schwab C, McGeer PL, McLarnon JG. Upregulation and expression patterns of the angiogenic transcription factor ets-1 in Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 37: 367-77. PMID 23948889 DOI: 10.3233/Jad-122191  0.35
2013 Lee M, McGeer E, Kodela R, Kashfi K, McGeer PL. NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders. Glia. 61: 1724-34. PMID 23918470 DOI: 10.1002/Glia.22553  0.337
2013 Wu Z, Sun L, Hashioka S, Yu S, Schwab C, Okada R, Hayashi Y, McGeer PL, Nakanishi H. Differential pathways for interleukin-1β production activated by chromogranin A and amyloid β in microglia. Neurobiology of Aging. 34: 2715-25. PMID 23831373 DOI: 10.1016/J.Neurobiolaging.2013.05.018  0.313
2013 Lee M, Guo JP, McGeer EG, McGeer PL. Aurin tricarboxylic acid self-protects by inhibiting aberrant complement activation at the C3 convertase and C9 binding stages. Neurobiology of Aging. 34: 1451-61. PMID 23177218 DOI: 10.1016/J.Neurobiolaging.2012.10.023  0.304
2013 Schwab C, Yu S, Wong W, McGeer EG, McGeer PL. GAD65, GAD67, and GABAT immunostaining in human brain and apparent GAD65 loss in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 33: 1073-88. PMID 23114513 DOI: 10.3233/Jad-2012-121330  0.398
2013 Lee M, McGeer E, McGeer PL. Neurotoxins released from interferon-gamma-stimulated human astrocytes. Neuroscience. 229: 164-75. PMID 23098801 DOI: 10.1016/J.Neuroscience.2012.10.033  0.37
2012 Hashioka S, Klegeris A, McGeer PL. Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers. Neuropharmacology. 63: 685-91. PMID 22659089 DOI: 10.1016/J.Neuropharm.2012.05.033  0.318
2012 Lee M, Guo JP, Schwab C, McGeer EG, McGeer PL. Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex. Neurobiology of Aging. 33: 2237-46. PMID 22217416 DOI: 10.1016/J.Neurobiolaging.2011.12.005  0.311
2012 Schwab C, Yu S, McGeer PL. Optineurin is colocalized with ubiquitin in Marinesco bodies. Acta Neuropathologica. 123: 289-92. PMID 22101367 DOI: 10.1007/S00401-011-0915-Y  0.358
2012 Schwab C, Yu S, McGeer EG, McGeer PL. Optineurin in Huntington's disease intranuclear inclusions. Neuroscience Letters. 506: 149-54. PMID 22085693 DOI: 10.1016/J.Neulet.2011.10.070  0.326
2012 Lee M, Kwon BM, Kwon BM, Suk K, McGeer E, McGeer PL. Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 173-86. PMID 21796424 DOI: 10.1007/S11481-011-9300-9  0.327
2012 Lee M, McGeer PL. Weak BMAA toxicity compares with that of the dietary supplement β-alanine. Neurobiology of Aging. 33: 1440-7. PMID 21236519 DOI: 10.1016/J.Neurobiolaging.2010.11.024  0.318
2012 Lee M, Schwab C, Yu S, McGeer E, McGeer P. P3-392: Induction of neuronal tau expression by conditioned medium from activated microglial cells Alzheimer's & Dementia. 8: P593-P593. DOI: 10.1016/J.Jalz.2012.05.2066  0.305
2012 Lee M, Guo J, Schwab C, McGeer E, McGeer P. P2-434: Aurin tricarboxylic acid may help Alzheimer's disease and other conditions by blocking the MAC of complement Alzheimer's & Dementia. 8: P418-P418. DOI: 10.1016/J.Jalz.2012.05.2059  0.322
2012 Schwab C, Yu S, Wong W, McGeer E, McGeer P. P2-417: GAD65, GAD67 and GABAT immunoreactivity in human brain and GAD65 loss in Alzheimer's disease Alzheimer's & Dementia. 8: P410-P410. DOI: 10.1016/J.Jalz.2012.05.2042  0.369
2012 Mclarnon J, Ling A, Jantaratnotai N, Schwab C, McGeer P. P4-044: Immunostaining evidence for angiogenic activity in Alzheimer's disease brain tissue Alzheimer's & Dementia. 8: P651-P651. DOI: 10.1016/J.Jalz.2012.05.1745  0.351
2011 McGeer PL, McGeer EG. History of innate immunity in neurodegenerative disorders. Frontiers in Pharmacology. 2: 77. PMID 22144960 DOI: 10.3389/Fphar.2011.00077  0.31
2011 Lee M, Kang Y, Suk K, Schwab C, Yu S, McGeer PL. Acidic fibroblast growth factor (FGF) potentiates glial-mediated neurotoxicity by activating FGFR2 IIIb protein. The Journal of Biological Chemistry. 286: 41230-45. PMID 21990352 DOI: 10.1074/Jbc.M111.270470  0.357
2011 Jantaratnotai N, Ryu JK, Schwab C, McGeer PL, McLarnon JG. Comparison of Vascular Perturbations in an Aβ-Injected Animal Model and in AD Brain. International Journal of Alzheimer's Disease. 2011: 918280. PMID 21969915 DOI: 10.4061/2011/918280  0.376
2011 Zou WQ, Xiao X, Yuan J, Puoti G, Fujioka H, Wang X, Richardson S, Zhou X, Zou R, Li S, Zhu X, McGeer PL, McGeehan J, Kneale G, Rincon-Limas DE, et al. Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain. The Journal of Biological Chemistry. 286: 15095-105. PMID 21393248 DOI: 10.1074/Jbc.M110.199356  0.355
2011 Hashioka S, Klegeris A, McGeer PL. Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes. Glia. 59: 833-40. PMID 21360757 DOI: 10.1002/Glia.21157  0.31
2010 Jantaratnotai N, Schwab C, Ryu JK, McGeer PL, McLarnon JG. Converging perturbed microvasculature and microglial clusters characterize Alzheimer disease brain. Current Alzheimer Research. 7: 625-36. PMID 20704556 DOI: 10.2174/156720510793499039  0.325
2010 Morawski M, Hartlage-Rübsamen M, Jäger C, Waniek A, Schilling S, Schwab C, McGeer PL, Arendt T, Demuth HU, Rossner S. Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease. Acta Neuropathologica. 120: 195-207. PMID 20383514 DOI: 10.1007/S00401-010-0685-Y  0.398
2010 Lee M, Tazzari V, Giustarini D, Rossi R, Sparatore A, Del Soldato P, McGeer E, McGeer PL. Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. The Journal of Biological Chemistry. 285: 17318-28. PMID 20368333 DOI: 10.1074/Jbc.M110.115261  0.3
2010 Lee M, Cho T, Jantaratnotai N, Wang YT, McGeer E, McGeer PL. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 2533-45. PMID 20228251 DOI: 10.1096/Fj.09-149997  0.351
2010 McGeer EG, McGeer PL. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. Journal of Alzheimer's Disease : Jad. 19: 355-61. PMID 20061650 DOI: 10.3233/Jad-2010-1219  0.383
2010 Guo JP, Yu S, McGeer PL. Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy. Journal of Alzheimer's Disease : Jad. 19: 1359-70. PMID 20061605 DOI: 10.3233/Jad-2010-1331  0.343
2010 Schwab C, Klegeris A, McGeer PL. Inflammation in transgenic mouse models of neurodegenerative disorders. Biochimica Et Biophysica Acta. 1802: 889-902. PMID 19883753 DOI: 10.1016/J.Bbadis.2009.10.013  0.348
2010 Lee M, Sparatore A, Del Soldato P, McGeer E, McGeer PL. Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia. 58: 103-13. PMID 19544392 DOI: 10.1002/Glia.20905  0.317
2010 Miklossy J, Qing H, Radenovic A, Kis A, Vileno B, Làszló F, Miller L, Martins RN, Waeber G, Mooser V, Bosman F, Khalili K, Darbinian N, McGeer PL. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiology of Aging. 31: 1503-15. PMID 18950899 DOI: 10.1016/J.Neurobiolaging.2008.08.019  0.316
2009 Hashioka S, McGeer PL, Monji A, Kanba S. Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease. Central Nervous System Agents in Medicinal Chemistry. 9: 12-9. PMID 20021334 DOI: 10.2174/187152409787601897  0.331
2009 Lee M, Schwab C, Yu S, McGeer E, McGeer PL. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiology of Aging. 30: 1523-34. PMID 19631409 DOI: 10.1016/J.Neurobiolaging.2009.06.001  0.322
2009 Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Höglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, ... ... McGeer PL, et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 297-309. PMID 19364361 DOI: 10.1111/J.1468-1331.2008.02513.X  0.338
2009 Schwab C, Arai T, Hasegawa M, Akiyama H, Yu S, McGeer PL. TDP-43 pathology in familial British dementia. Acta Neuropathologica. 118: 303-11. PMID 19283396 DOI: 10.1007/S00401-009-0514-3  0.357
2009 Hashioka S, Klegeris A, McGeer PL. Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity. Experimental Neurology. 217: 177-83. PMID 19232345 DOI: 10.1016/J.Expneurol.2009.02.002  0.315
2009 Hashioka S, Klegeris A, Schwab C, McGeer PL. Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiology of Aging. 30: 1924-35. PMID 18375019 DOI: 10.1016/J.Neurobiolaging.2008.02.019  0.362
2009 Hashioka S, McGeer PL. Complexity of microglial activation state: Can modifying microglial activation treat Alzheimer's disease? Future Neurology. 4: 137-139. DOI: 10.2217/14796708.4.2.137  0.32
2008 Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. Journal of Neuropathology and Experimental Neurology. 67: 1159-65. PMID 19018245 DOI: 10.1097/Nen.0B013E31818E8951  0.344
2008 Miklossy J, Steele JC, Yu S, McCall S, Sandberg G, McGeer EG, McGeer PL. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). Acta Neuropathologica. 116: 625-37. PMID 18843496 DOI: 10.1007/S00401-008-0439-2  0.363
2008 Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, ... ... McGeer PL, et al. Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. Journal of Neuroinflammation. 5: 36. PMID 18715507 DOI: 10.1186/1742-2094-5-36  0.377
2008 Hashioka S, Miklossy J, Schwab C, Klegeris A, McGeer PL. Adhesion of exogenous human microglia and THP-1 cells to amyloid plaques of postmortem Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 14: 345-52. PMID 18599961 DOI: 10.3233/Jad-2008-14309  0.386
2008 Villoslada P, Moreno B, Melero I, Pablos JL, Martino G, Uccelli A, Montalban X, Avila J, Rivest S, Acarin L, Appel S, Khoury SJ, McGeer P, Ferrer I, Delgado M, et al. Immunotherapy for neurological diseases. Clinical Immunology (Orlando, Fla.). 128: 294-305. PMID 18534912 DOI: 10.1016/J.Clim.2008.04.003  0.301
2008 McGeer PL, McGeer EG. The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease. Experimental Neurology. 212: 235-8. PMID 18514193 DOI: 10.1016/J.Expneurol.2008.04.008  0.317
2008 Schwab C, McGeer PL. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. Journal of Alzheimer's Disease : Jad. 13: 359-69. PMID 18487845 DOI: 10.3233/Jad-2008-13402  0.309
2008 Klegeris A, Li J, Bammler TK, Jin J, Zhu D, Kashima DT, Pan S, Hashioka S, Maguire J, McGeer PL, Zhang J. Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity. Glia. 56: 675-85. PMID 18293395 DOI: 10.1002/Glia.20645  0.319
2008 McGeer PL, McGeer EG. Glial reactions in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 474-83. PMID 18044695 DOI: 10.1002/Mds.21751  0.323
2008 Miklossy J, Fein LA, McCall S, Kasas S, McGeer PL. P1-378: Concurrent Alzheimer's disease and Lyme neuroborreliosis: Persisting atypical cystic Forms of Borrelia burgdorferi in the brain and recovery of cognitive decline following antibiotic treatment Alzheimer's & Dementia. 4: T329-T330. DOI: 10.1016/J.Jalz.2008.05.960  0.321
2007 McGeer EG, McGeer PL. The role of anti-inflammatory agents in Parkinson's disease. Cns Drugs. 21: 789-97. PMID 17850169 DOI: 10.2165/00023210-200721100-00001  0.363
2007 Miklossy J, Qing H, Guo JP, Yu S, Wszolek ZK, Calne D, McGeer EG, McGeer PL. Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation. Acta Neuropathologica. 114: 243-54. PMID 17639429 DOI: 10.1007/S00401-007-0230-9  0.37
2007 Klegeris A, Choi HB, McLarnon JG, McGeer PL. Functional ryanodine receptors are expressed by human microglia and THP-1 cells: Their possible involvement in modulation of neurotoxicity. Journal of Neuroscience Research. 85: 2207-15. PMID 17526017 DOI: 10.1002/Jnr.21361  0.326
2007 Klegeris A, McGeer EG, McGeer PL. Therapeutic approaches to inflammation in neurodegenerative disease. Current Opinion in Neurology. 20: 351-7. PMID 17495632 DOI: 10.1097/Wco.0B013E3280Adc943  0.319
2007 Klegeris A, McGeer PL. Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112. Biochemical and Biophysical Research Communications. 357: 1096-9. PMID 17459337 DOI: 10.1016/J.Bbrc.2007.04.055  0.337
2007 Klegeris A, Schulzer M, Harper DG, McGeer PL. Increase in core body temperature of Alzheimer's disease patients as a possible indicator of chronic neuroinflammation: a meta-analysis. Gerontology. 53: 7-11. PMID 16940734 DOI: 10.1159/000095386  0.379
2007 McGeer PL, McGeer EG. NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiology of Aging. 28: 639-47. PMID 16697488 DOI: 10.1016/J.Neurobiolaging.2006.03.013  0.337
2006 Miklossy J, Arai T, Guo JP, Klegeris A, Yu S, McGeer EG, McGeer PL. LRRK2 expression in normal and pathologic human brain and in human cell lines. Journal of Neuropathology and Experimental Neurology. 65: 953-63. PMID 17021400 DOI: 10.1097/01.Jnen.0000235121.98052.54  0.402
2006 McGeer PL, Rogers J, McGeer EG. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. Journal of Alzheimer's Disease : Jad. 9: 271-6. PMID 16914866 DOI: 10.3233/Jad-2006-9S330  0.373
2006 Guo JP, Arai T, Miklossy J, McGeer PL. Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 1953-8. PMID 16446437 DOI: 10.1073/Pnas.0509386103  0.341
2006 Arai T, Miklossy J, Klegeris A, Guo JP, McGeer PL. Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. Journal of Neuropathology and Experimental Neurology. 65: 19-25. PMID 16410745 DOI: 10.1097/01.Jnen.0000196133.74087.Cb  0.413
2005 McGeer EG, McGeer PL. Abeta immunotherapy and other means to remove amyloid. Current Drug Targets. Cns and Neurological Disorders. 4: 569-73. PMID 16266289 DOI: 10.2174/156800705774322067  0.336
2005 McGeer EG, Klegeris A, McGeer PL. Inflammation, the complement system and the diseases of aging. Neurobiology of Aging. 26: 94-7. PMID 16198446 DOI: 10.1016/J.Neurobiolaging.2005.08.008  0.37
2005 Klegeris A, McGeer PL. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease. Current Alzheimer Research. 2: 355-65. PMID 15974901 DOI: 10.2174/1567205054367883  0.373
2005 Miklossy J, Mackenzie IR, Dorovini-Zis K, Calne DB, Wszolek ZK, Klegeris A, McGeer PL. Severe vascular disturbance in a case of familial brain calcinosis. Acta Neuropathologica. 109: 643-53. PMID 15937691 DOI: 10.1007/S00401-005-1007-7  0.309
2005 Klegeris A, McGeer PL. Chymotrypsin-like proteases contribute to human monocytic THP-1 cell as well as human microglial neurotoxicity. Glia. 51: 56-64. PMID 15779083 DOI: 10.1002/Glia.20186  0.391
2005 McGeer EG, McGeer PL. Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 19: 31-7. PMID 15691215 DOI: 10.2165/00063030-200519010-00004  0.302
2005 Arai T, Guo JP, McGeer PL. Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. The Journal of Biological Chemistry. 280: 5145-53. PMID 15542598 DOI: 10.1074/Jbc.M409234200  0.35
2004 McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Annals of the New York Academy of Sciences. 1035: 104-16. PMID 15681803 DOI: 10.1196/Annals.1332.007  0.381
2004 Hosokawa M, Klegeris A, McGeer PL. Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs. Journal of Neuroinflammation. 1: 17. PMID 15327690 DOI: 10.1186/1742-2094-1-17  0.308
2004 McGeer PL, McGeer E. Immunotherapy for Alzheimer's disease. Science of Aging Knowledge Environment : Sage Ke. 2004: pe29. PMID 15243154 DOI: 10.1126/Sageke.2004.27.Pe29  0.381
2004 Klegeris A, Maguire J, McGeer PL. S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicity. Journal of Neuroimmunology. 152: 73-7. PMID 15223239 DOI: 10.1016/J.Jneuroim.2004.04.001  0.329
2004 Schwab C, Hosokawa M, McGeer PL. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Experimental Neurology. 188: 52-64. PMID 15191802 DOI: 10.1016/J.Expneurol.2004.03.016  0.338
2004 McGeer PL, McGeer EG. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism & Related Disorders. 10: S3-7. PMID 15109580 DOI: 10.1016/J.Parkreldis.2004.01.005  0.31
2004 Akiyama H, McGeer PL. Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease. Nature Medicine. 10: 117-8; author reply . PMID 14760408 DOI: 10.1038/Nm0204-117  0.315
2004 Akiyama H, Kondo H, Arai T, Ikeda K, Kato M, Iseki E, Schwab C, McGeer PL. Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathologica. 107: 53-8. PMID 14586629 DOI: 10.1007/S00401-003-0783-1  0.393
2004 Miklossy J, Arai T, Schwab C, Steele JC, McGeer PL. P3-368 Neuronal and glial fibrillary tangles in parkinsonism dementia of Guam are more extensive and severe than in Alzheimer disease and other tauopathies Neurobiology of Aging. 25: S460. DOI: 10.1016/S0197-4580(04)81517-3  0.36
2004 Miklossy J, Reiss K, Darbinian N, Khalili K, McGeer PL, Miklossy J. P2-136 Lipopolysaccharide (LPS) simultaneously induces the two most important biological markers of Alzheimer's disease Neurobiology of Aging. 25: S263. DOI: 10.1016/S0197-4580(04)80883-2  0.308
2003 McGeer PL, Schwab C, Parent A, Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Annals of Neurology. 54: 599-604. PMID 14595649 DOI: 10.1002/Ana.10728  0.307
2003 McGeer EG, McGeer PL. Inflammatory processes in Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 741-9. PMID 12921904 DOI: 10.1016/S0278-5846(03)00124-6  0.415
2003 Schwab C, Hosokawa M, Akiyama H, McGeer PL. Familial British dementia: colocalization of furin and ABri amyloid. Acta Neuropathologica. 106: 278-84. PMID 12883829 DOI: 10.1007/S00401-003-0735-9  0.379
2003 McGeer EG, McGeer PL. Clinically tested drugs for Alzheimer's disease. Expert Opinion On Investigational Drugs. 12: 1143-51. PMID 12831349 DOI: 10.1517/13543784.12.7.1143  0.36
2003 Klegeris A, McGeer PL. Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP. Journal of Leukocyte Biology. 73: 369-78. PMID 12629151 DOI: 10.1189/Jlb.1002482  0.322
2003 McGeer PL, McGeer E. Is there a future for vaccination as a treatment for Alzheimer's disease? Neurobiology of Aging. 24: 391-5. PMID 12600715 DOI: 10.1016/S0197-4580(02)00157-4  0.317
2002 McGeer PL, McGeer EG. Innate immunity, local inflammation, and degenerative disease. Science of Aging Knowledge Environment : Sage Ke. 2002: re3. PMID 14602998 DOI: 10.1126/Sageke.2002.29.Re3  0.389
2002 McGeer PL, McGeer EG. Local neuroinflammation and the progression of Alzheimer's disease. Journal of Neurovirology. 8: 529-38. PMID 12476347 DOI: 10.1080/13550280290100969  0.381
2002 McGeer PL, McGeer EG. The possible role of complement activation in Alzheimer disease. Trends in Molecular Medicine. 8: 519-23. PMID 12421685 DOI: 10.1016/S1471-4914(02)02422-X  0.383
2002 Klegeris A, McGeer PL. Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiology of Aging. 23: 787-94. PMID 12392782 DOI: 10.1016/S0197-4580(02)00021-0  0.345
2002 Morris HR, Baker M, Yasojima K, Houlden H, Khan MN, Wood NW, Hardy J, Grossman M, Trojanowski J, Revesz T, Bigio EH, Bergeron C, Janssen JC, McGeer PL, Rossor MN, et al. Analysis of tau haplotypes in Pick's disease. Neurology. 59: 443-5. PMID 12177383 DOI: 10.1212/Wnl.59.3.443  0.308
2002 Klegeris A, Liutkevicius E, Mikalauskiene G, Duburs G, McGeer PL, Klusa V. Anti-inflammatory effects of cerebrocrast in a model of rat paw edema and on mononuclear THP-1 cells. European Journal of Pharmacology. 441: 203-8. PMID 12063093 DOI: 10.1016/S0014-2999(02)01262-1  0.352
2001 McGeer EG, McGeer PL. Chronic inflammation in Alzheimer's disease offers therapeutic opportunities. Expert Review of Neurotherapeutics. 1: 53-60. PMID 19811046 DOI: 10.1586/14737175.1.1.53  0.398
2001 McGeer EG, Yasojima K, Schwab C, McGeer PL. The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases. Neurobiology of Aging. 22: 843-8. PMID 11754991 DOI: 10.1016/S0197-4580(01)00288-3  0.409
2001 McGeer PL, McGeer EG. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Archives of Neurology. 58: 1790-2. PMID 11708985 DOI: 10.1001/Archneur.58.11.1790  0.322
2001 Akiyama H, Kondo H, Ikeda K, Kato M, McGeer PL. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. Brain Research. 902: 277-81. PMID 11384622 DOI: 10.1016/S0006-8993(01)02390-3  0.339
2001 Arai T, Ikeda K, Akiyama H, Shikamoto Y, Tsuchiya K, Yagishita S, Beach T, Rogers J, Schwab C, McGeer PL. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathologica. 101: 167-73. PMID 11271372 DOI: 10.1007/S004010000283  0.382
2001 Yasojima K, Akiyama H, McGeer EG, McGeer PL. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neuroscience Letters. 297: 97-100. PMID 11121879 DOI: 10.1016/S0304-3940(00)01675-X  0.368
2000 Yasojima K, Schwab C, McGeer EG, McGeer PL. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Research. 887: 80-9. PMID 11134592 DOI: 10.1016/S0006-8993(00)02970-X  0.407
2000 Klegeris A, McGeer PL. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition. Experimental Neurology. 166: 458-64. PMID 11085911 DOI: 10.1006/Exnr.2000.7517  0.319
2000 McGeer PL, McGeer EG, Yasojima K. Alzheimer disease and neuroinflammation. Journal of Neural Transmission. Supplementum. 59: 53-7. PMID 10961418 DOI: 10.1007/978-3-7091-6781-6_8  0.402
2000 McGeer PL. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease. Drugs & Aging. 17: 1-11. PMID 10933512 DOI: 10.2165/00002512-200017010-00001  0.37
2000 Schwab C, DeMaggio AJ, Ghoshal N, Binder LI, Kuret J, McGeer PL. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiology of Aging. 21: 503-10. PMID 10924763 DOI: 10.1016/S0197-4580(00)00110-X  0.354
2000 Cooper NR, Kalaria RN, McGeer PL, Rogers J. Key issues in Alzheimer's disease inflammation. Neurobiology of Aging. 21: 451-453. PMID 10858594 DOI: 10.1016/S0197-4580(00)00148-2  0.353
2000 Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, ... ... McGeer PL, et al. Inflammation and Alzheimer's disease. Neurobiology of Aging. 21: 383-421. PMID 10858586 DOI: 10.1016/S0197-4580(00)00124-X  0.388
2000 Yasojima K, Kuret J, DeMaggio AJ, McGeer E, McGeer PL. Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain. Brain Research. 865: 116-20. PMID 10814741 DOI: 10.1016/S0006-8993(00)02200-9  0.382
2000 Klegeris A, McGeer EG, McGeer PL. Inhibitory action of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxam ide (PK 11195) on some mononuclear phagocyte functions. Biochemical Pharmacology. 59: 1305-14. PMID 10736431 DOI: 10.1016/S0006-2952(00)00252-5  0.305
2000 Klegeris A, McGeer PL. Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. Journal of Leukocyte Biology. 67: 127-33. PMID 10648007 DOI: 10.1002/Jlb.67.1.127  0.363
1999 Schwab C, Schulzer M, Steele JC, McGeer PL. On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam. Neurobiology of Aging. 20: 57-63. PMID 10466894 DOI: 10.1016/S0197-4580(99)00005-6  0.327
1999 Klegeris A, Walker DG, McGeer PL. Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs). Neuropharmacology. 38: 1017-25. PMID 10428420 DOI: 10.1016/S0028-3908(99)00014-3  0.356
1999 Yasojima K, McGeer EG, McGeer PL. Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease. Brain Research. 833: 297-301. PMID 10375708 DOI: 10.1016/S0006-8993(99)01514-0  0.316
1999 Yasojima K, Schwab C, McGeer EG, McGeer PL. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Research. 830: 226-36. PMID 10366679 DOI: 10.1016/S0006-8993(99)01389-X  0.379
1999 McGeer PL, McGeer EG. Inflammation of the brain in Alzheimer's disease: implications for therapy. Journal of Leukocyte Biology. 65: 409-15. PMID 10204568 DOI: 10.1002/Jlb.65.4.409  0.402
1999 Yasojima K, Schwab C, McGeer EG, McGeer PL. Up-regulated production and activation of the complement system in Alzheimer's disease brain. The American Journal of Pathology. 154: 927-36. PMID 10079271 DOI: 10.1016/S0002-9440(10)65340-0  0.357
1999 Akiyama H, Mori H, Saido T, Kondo H, Ikeda K, McGeer PL. Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease. Glia. 25: 324-31. PMID 10028915 DOI: 10.1002/(Sici)1098-1136(19990215)25:4<324::Aid-Glia2>3.0.Co;2-5  0.333
1998 Schwab C, Akiyama H, McGeer EG, McGeer PL. Extracellular neurofibrillary tangles are immunopositive for the 40 carboxy-terminal sequence of beta-amyloid protein. Journal of Neuropathology and Experimental Neurology. 57: 1131-7. PMID 9862635 DOI: 10.1097/00005072-199812000-00004  0.338
1998 McGeer PL, McGeer EG. Mechanisms of cell death in Alzheimer disease--immunopathology. Journal of Neural Transmission. Supplementum. 54: 159-66. PMID 9850924 DOI: 10.1007/978-3-7091-7508-8_15  0.302
1998 Walker DG, Kim SU, McGeer PL. Expression of complement C4 and C9 genes by human astrocytes. Brain Research. 809: 31-8. PMID 9795119 DOI: 10.1016/S0006-8993(98)00811-7  0.323
1998 McGeer PL, McGeer EG. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Disease and Associated Disorders. 12: S1-6. PMID 9769023 DOI: 10.1097/00002093-199803001-00001  0.413
1998 McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer disease. Experimental Gerontology. 33: 371-8. PMID 9762518 DOI: 10.1016/S0531-5565(98)00013-8  0.416
1998 Takami K, Matsuo A, Terai K, Walker DG, McGeer EG, McGeer PL. Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease. Brain Research. 802: 89-97. PMID 9748519 DOI: 10.1016/S0006-8993(98)00552-6  0.373
1998 McGeer PL, Kawamata T, McGeer EG. Localization and possible functions of presenilins in brain. Reviews in the Neurosciences. 9: 1-15. PMID 9683324 DOI: 10.1515/Revneuro.1998.9.1.1  0.376
1998 Walker DG, Terai K, Matsuo A, Beach TG, McGeer EG, McGeer PL. Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases. Brain Research. 794: 181-7. PMID 9622624 DOI: 10.1016/S0006-8993(98)00132-2  0.302
1998 McGeer EG, McGeer PL. The future use of complement inhibitors for the treatment of neurological diseases. Drugs. 55: 739-46. PMID 9617589 DOI: 10.2165/00003495-199855060-00001  0.323
1998 Walker DG, Beach TG, Xu R, Lile J, Beck KD, McGeer EG, McGeer PL. Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease. Brain Research. 792: 207-17. PMID 9593897 DOI: 10.1016/S0006-8993(98)00131-0  0.34
1997 Wszolek ZK, Vieregge P, Uitti RJ, Gasser T, Yasuhara O, McGeer P, Berry K, Calne DB, Vingerhoets FJ, Klein C, Pfeiffer RF. German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations. Parkinsonism & Related Disorders. 3: 125-39. PMID 18591067 DOI: 10.1016/S1353-8020(97)00013-8  0.341
1997 Shen Y, Li R, McGeer EG, McGeer PL. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Research. 769: 391-5. PMID 9374212 DOI: 10.1016/S0006-8993(97)00850-0  0.357
1997 Akiyama H, Mori H, Sahara N, Kondo H, Ikeda K, Nishimura T, Oda T, McGeer PL. Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specific for A beta 40 and the A beta that ends at residues alanine42/threonine43 (A beta 42). Neurochemical Research. 22: 1499-506. PMID 9357016 DOI: 10.1023/A:1021910729963  0.348
1997 Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiology of Aging. 18: 415-21. PMID 9330973 DOI: 10.1016/S0197-4580(97)00042-0  0.403
1997 Klegeris A, McGeer PL. beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. Journal of Neuroscience Research. 49: 229-35. PMID 9272645 DOI: 10.1002/(Sici)1097-4547(19970715)49:2<229::Aid-Jnr11>3.0.Co;2-W  0.341
1997 Yasuhara O, Matsuo A, Terai K, Walker DG, Berger AE, Akiguchi I, Kimura J, McGeer PL. Expression of interleukin-1 receptor antagonist protein in post-mortem human brain tissues of Alzheimer's disease and control cases. Acta Neuropathologica. 93: 414-20. PMID 9113207 DOI: 10.1007/S004010050633  0.371
1997 McGeer PL, Walker DG, Pitas RE, Mahley RW, McGeer EG. Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro. Brain Research. 749: 135-8. PMID 9070638 DOI: 10.1016/S0006-8993(96)01324-8  0.312
1997 Takami K, Terai K, Matsuo A, Walker DG, McGeer PL. Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains. Brain Research. 748: 122-30. PMID 9067452 DOI: 10.1016/S0006-8993(96)01274-7  0.375
1997 Klegeris A, Walker DG, McGeer PL. Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha. Brain Research. 747: 114-21. PMID 9042534 DOI: 10.1016/S0006-8993(96)01229-2  0.344
1997 McGeer EG, McGeer PL. Inflammatory Cytokines in the CNS Cns Drugs. 7: 214-228. DOI: 10.2165/00023210-199707030-00005  0.349
1996 Aimi Y, McGeer PL. Lack of toxicity of human neuromelanin to rat brain dopaminergic neurons. Parkinsonism & Related Disorders. 2: 69-74. PMID 18591021 DOI: 10.1016/1353-8020(96)00004-1  0.337
1996 Matsuo A, Walker DG, Terai K, McGeer PL. Expression of CD43 in human microglia and its downregulation in Alzheimer's disease. Journal of Neuroimmunology. 71: 81-6. PMID 8982106 DOI: 10.1016/S0165-5728(96)00134-8  0.35
1996 Akiyama H, Kondo H, Mori H, Kametani F, Nishimura T, Ikeda K, Kato M, McGeer PL. The amino-terminally truncated forms of amyloid beta-protein in brain macrophages in the ischemic lesions of Alzheimer's disease patients. Neuroscience Letters. 219: 115-8. PMID 8971793 DOI: 10.1016/S0304-3940(96)13197-9  0.388
1996 Terai K, Matsuo A, McGeer EG, McGeer PL. Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctions. Brain Research. 739: 343-9. PMID 8955958 DOI: 10.1016/S0006-8993(96)01073-6  0.315
1996 Schwab C, Steele JC, McGeer PL. Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins. Brain Research. 707: 196-205. PMID 8919296 DOI: 10.1016/0006-8993(95)01257-5  0.37
1996 Yasuhara O, Schwab C, Matsuo A, Kim SU, Steele JC, Akiguchi I, Kimura J, McGeer EG, McGeer PL. Midkine-like immunoreactivity in extracellular neurofibrillary tangles in brains of patients with parkinsonism-dementia complex of Guam. Neuroscience Letters. 205: 107-10. PMID 8907328 DOI: 10.1016/0304-3940(96)12385-5  0.4
1996 Terai K, Matsuo A, McGeer PL. Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Research. 735: 159-68. PMID 8905182 DOI: 10.1016/0006-8993(96)00310-1  0.355
1996 Rogers J, Webster S, Lue LF, Brachova L, Civin WH, Emmerling M, Shivers B, Walker D, McGeer P. Inflammation and Alzheimer's disease pathogenesis. Neurobiology of Aging. 17: 681-6. PMID 8892340 DOI: 10.1016/0197-4580(96)00115-7  0.379
1996 Schwab C, Steele JC, Akiyama H, McGeer PL. Distinct distribution of apolipoprotein E and beta-amyloid immunoreactivity in the hippocampus of Parkinson dementia complex of Guam. Acta Neuropathologica. 92: 378-85. PMID 8891070 DOI: 10.1007/S004010050533  0.37
1996 McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 47: 425-32. PMID 8757015 DOI: 10.1212/Wnl.47.2.425  0.326
1996 Yasuhara O, Akiguchi I, Nakamura S, Kinoshita A, Ikemoto A, Kawamoto Y, Kimura J, Funakoshi A, Tateishi K, McGeer PL. Pancreastatin-like immunoreactivity in globular dystrophic neurites of senile plaques in brains of patients with Alzheimer's disease. Neuroscience Letters. 208: 167-70. PMID 8733296 DOI: 10.1016/0304-3940(96)12573-8  0.407
1996 Akiyama H, Schwab C, Kondo H, Mori H, Kametani F, Ikeda K, McGeer PL. Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein. Neuroscience Letters. 206: 169-72. PMID 8710178 DOI: 10.1016/S0304-3940(96)12474-5  0.378
1996 Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, Yasuhara O, McGeer PL. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Research. 712: 122-6. PMID 8705294 DOI: 10.1016/0006-8993(95)01407-1  0.368
1996 Rothenberger S, Food MR, Gabathuler R, Kennard ML, Yamada T, Yasuhara O, McGeer PL, Jefferies WA. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium. Brain Research. 712: 117-21. PMID 8705293 DOI: 10.1016/0006-8993(96)88505-2  0.301
1996 Oken RJ, McGeer PL. Schizophrenia, Alzheimer's disease, and anti-inflammatory agents. Schizophrenia Bulletin. 22: 1-4. PMID 8685652 DOI: 10.1093/Schbul/22.1.1  0.304
1996 McGeer PL, McGeer EG. Anti-inflammatory drugs in the fight against Alzheimer's disease. Annals of the New York Academy of Sciences. 777: 213-20. PMID 8624086 DOI: 10.1111/J.1749-6632.1996.Tb34421.X  0.38
1996 McGeer P, Schulzer M, McGeer E. 807 Evidence supporting the inflammatory hypothesis of Alzheimer disease Neurobiology of Aging. 17: S201. DOI: 10.1016/S0197-4580(96)80809-8  0.348
1996 Kawamata T, Hashimoto T, Taniguchi T, Niu S, Nakai M, Yasuda M, Tcrashima A, Macda K, Nishimura A, Tatsuno Y, Akiguchi I, McGeer P, Tanaka C. 547 Presenilin-1 (S182) immunobistochemistry in Alzheimer brain tissues Neurobiology of Aging. 17: S136. DOI: 10.1016/S0197-4580(96)80549-5  0.332
1996 Akiyama H, Schwab C, Kondo H, Mori H, Kametani F, Ikeda K, McGeer PL. 419 Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80421-0  0.333
1996 Takami K, Walker D, McGeer P. 71 Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer brains Neurobiology of Aging. 17: S18. DOI: 10.1016/S0197-4580(96)80073-X  0.313
1995 Uitti RJ, Berry K, Yasuhara O, Eisen A, Feldman H, McGeer PL, Calne DB. Neurodegenerative 'overlap' syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease. Parkinsonism & Related Disorders. 1: 21-34. PMID 18590998 DOI: 10.1016/1353-8020(95)00004-P  0.341
1995 McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Research. Brain Research Reviews. 21: 195-218. PMID 8866675 DOI: 10.1016/0165-0173(95)00011-9  0.395
1995 Tooyama I, Kawamata T, Akiyama H, Kimura H, Moestrup SK, Gliemann J, Matsuo A, McGeer PL. Subcellular localization of the low density lipoprotein receptor-related protein (alpha 2-macroglobulin receptor) in human brain. Brain Research. 691: 235-8. PMID 8590059 DOI: 10.1016/0006-8993(95)00735-9  0.31
1995 Schwab C, Steele JC, Akiyama H, McGeer EG, McGeer PL. Relationship of amyloid beta/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia. Acta Neuropathologica. 90: 287-98. PMID 8525803 DOI: 10.1007/Bf00296513  0.381
1995 Oken RJ, McGeer PL. Down's syndrome: prophylaxis and therapy for the frequently comorbid Alzheimer's disease. Medical Hypotheses. 44: 233-4. PMID 7666820 DOI: 10.1016/0306-9877(95)90170-1  0.364
1995 Walker DG, Kim SU, McGeer PL. Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. Journal of Neuroscience Research. 40: 478-93. PMID 7616608 DOI: 10.1002/Jnr.490400407  0.306
1995 Yasuhara O, Matsuo A, Tooyama I, Kimura H, McGeer EG, McGeer PL. Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons. Acta Neuropathologica. 89: 322-30. PMID 7610763 DOI: 10.1007/Bf00309625  0.394
1995 Oken RJ, McGeer PL. Human prion diseases: possible new directions in prophylaxis and therapy. Medical Hypotheses. 44: 167-8. PMID 7609669 DOI: 10.1016/0306-9877(95)90130-2  0.418
1994 Yasuhara O, Akiyama H, McGeer EG, McGeer PL. Immunohistochemical localization of hyaluronic acid in rat and human brain. Brain Research. 635: 269-82. PMID 8173963 DOI: 10.1016/0006-8993(94)91448-6  0.348
1994 Akiyama H, Tooyama I, Kondo H, Ikeda K, Kimura H, McGeer EG, McGeer PL. Early response of brain resident microglia to kainic acid-induced hippocampal lesions. Brain Research. 635: 257-68. PMID 8173962 DOI: 10.1016/0006-8993(94)91447-8  0.332
1994 Akiyama H, Ikeda K, Katoh M, McGeer EG, McGeer PL. Expression of MRP14, 27E10, interferon-alpha and leukocyte common antigen by reactive microglia in postmortem human brain tissue. Journal of Neuroimmunology. 50: 195-201. PMID 8120141 DOI: 10.1016/0165-5728(94)90046-9  0.38
1994 Yasuhara O, Kawamata T, Aimi Y, McGeer EG, McGeer PL. Two types of dystrophic neurites in senile plaques of Alzheimer disease and elderly non-demented cases. Neuroscience Letters. 171: 73-6. PMID 8084503 DOI: 10.1016/0304-3940(94)90608-4  0.34
1994 Yasuhara O, Aimi Y, McGeer EG, McGeer PL. Accumulation of amyloid precursor protein in brain lesions of patients with Pick disease. Neuroscience Letters. 171: 63-6. PMID 8084502 DOI: 10.1016/0304-3940(94)90605-X  0.369
1994 Itagaki S, Akiyama H, Saito H, McGeer PL. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease. Brain Research. 645: 78-84. PMID 8062101 DOI: 10.1016/0006-8993(94)91640-3  0.374
1994 Yasuhara O, Kawamata T, Aimi Y, McGeer EG, McGeer PL. Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases. Neuroscience Letters. 170: 13-6. PMID 8041489 DOI: 10.1016/0304-3940(94)90227-5  0.389
1994 Moroo I, Yamada T, Makino H, Tooyama I, McGeer PL, McGeer EG, Hirayama K. Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease. Acta Neuropathologica. 87: 343-8. PMID 8017169 DOI: 10.1007/Bf00313602  0.334
1994 Yasuhara O, Walker DG, McGeer PL. Hageman factor and its binding sites are present in senile plaques of Alzheimer's disease. Brain Research. 654: 234-40. PMID 7987673 DOI: 10.1016/0006-8993(94)90484-7  0.366
1994 McGeer PL, Rogers J, McGeer EG. Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alzheimer Disease and Associated Disorders. 8: 149-58. PMID 7986484 DOI: 10.1097/00002093-199408030-00001  0.352
1994 Tooyama I, McGeer EG, Kawamata T, Kimura H, McGeer PL. Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrasts with loss in Parkinson's disease. Brain Research. 656: 165-8. PMID 7804831 DOI: 10.1016/0006-8993(94)91378-1  0.319
1994 McGeer PL, Klegeris A, Walker DG, Yasuhara O, McGeer EG. Pathological proteins in senile plaques. The Tohoku Journal of Experimental Medicine. 174: 269-77. PMID 7761992 DOI: 10.1620/Tjem.174.269  0.353
1994 Kimura H, Tooyama I, McGeer PL. Acidic FGF expression in the surroundings of senile plaques. The Tohoku Journal of Experimental Medicine. 174: 279-93. PMID 7539161 DOI: 10.1620/Tjem.174.279  0.381
1994 Hara Y, Tooyama I, Yasuhara O, Akiyama H, McGeer PL, Handa J, Kimura H. Acidic fibroblast growth factor-like immunoreactivity in rat brain following cerebral infarction. Brain Research. 664: 101-7. PMID 7534599 DOI: 10.1016/0006-8993(94)91959-3  0.306
1994 Yasuhara O, Aimi Y, McGeer EG, McGeer PL. Expression of the complement membrane attack complex and its inhibitors in Pick disease brain. Brain Research. 652: 346-9. PMID 7525023 DOI: 10.1016/0006-8993(94)90246-1  0.362
1994 Akiyama H, Nishimura T, Kondo H, Ikeda K, Hayashi Y, McGeer PL. Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis. Brain Research. 639: 171-4. PMID 7514086 DOI: 10.1016/0006-8993(94)91779-5  0.36
1993 Tooyama I, Kawamata T, Akiyama H, Moestrup SK, Gliemann J, McGeer PL. Immunohistochemical study of alpha 2 macroglobulin receptor in Alzheimer and control postmortem human brain. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 18: 153-60. PMID 8466589 DOI: 10.1007/Bf03160029  0.395
1993 Mizukawa K, McGeer EG, McGeer PL. Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 18: 133-44. PMID 8466587 DOI: 10.1007/Bf03160027  0.303
1993 McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia. 7: 84-92. PMID 8423066 DOI: 10.1002/Glia.440070114  0.386
1993 Akiyama H, Kawamata T, Yamada T, Tooyama I, Ishii T, McGeer PL. Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders. Acta Neuropathologica. 85: 628-34. PMID 8337942 DOI: 10.1007/Bf00334673  0.408
1993 Yasuhara O, Hanai K, Ohkubo I, Sasaki M, McGeer PL, Kimura H. Expression of cystatin C in rat, monkey and human brains. Brain Research. 628: 85-92. PMID 8313175 DOI: 10.1016/0006-8993(93)90941-F  0.341
1993 Akiyama H, Ikeda K, Kondo H, Kato M, McGeer PL. Microglia express the type 2 plasminogen activator inhibitor in the brain of control subjects and patients with Alzheimer's disease. Neuroscience Letters. 164: 233-5. PMID 8152607 DOI: 10.1016/0304-3940(93)90899-V  0.395
1993 Tooyama I, Kremer HP, Hayden MR, Kimura H, McGeer EG, McGeer PL. Acidic and basic fibroblast growth factor-like immunoreactivity in the striatum and midbrain in Huntington's disease. Brain Research. 610: 1-7. PMID 7686078 DOI: 10.1016/0006-8993(93)91209-B  0.346
1993 Akiyama H, Tooyama I, Kawamata T, Ikeda K, McGeer PL. Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer's disease. Brain Research. 632: 249-59. PMID 7511977 DOI: 10.1016/0006-8993(93)91160-T  0.306
1992 McGeer PL, Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology. 42: 447-9. PMID 1736183 DOI: 10.1212/Wnl.42.2.447  0.383
1992 Akiyama H, Ikeda K, Kondo H, McGeer PL. Thrombin accumulation in brains of patients with Alzheimer's disease. Neuroscience Letters. 146: 152-4. PMID 1491781 DOI: 10.1016/0304-3940(92)90065-F  0.393
1992 Shigematsu K, McGeer PL. Accumulation of amyloid precursor protein in damaged neuronal processes and microglia following intracerebral administration of aluminum salts. Brain Research. 593: 117-23. PMID 1458313 DOI: 10.1016/0006-8993(92)91272-G  0.388
1992 Tooyama I, Walker D, Yamada T, Hanai K, Kimura H, McGeer EG, McGeer PL. High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain. Brain Research. 593: 274-80. PMID 1450935 DOI: 10.1016/0006-8993(92)91318-9  0.304
1992 Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P. Complement activation by beta-amyloid in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 89: 10016-20. PMID 1438191 DOI: 10.1073/Pnas.89.21.10016  0.339
1992 Walker DG, McGeer PL. Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Brain Research. Molecular Brain Research. 14: 109-16. PMID 1323007 DOI: 10.1016/0169-328X(92)90017-6  0.353
1992 Tooyama I, Yamada T, Kim SU, McGeer PL. Immunohistochemical study of A2B5-positive ganglioside in postmortem human brain tissue of Alzheimer disease, amyotrophic lateral sclerosis, progressive supranuclear palsy and control cases. Neuroscience Letters. 136: 91-4. PMID 1321969 DOI: 10.1016/0304-3940(92)90655-Q  0.348
1992 Yamada T, McGeer PL, McGeer EG. Some immunohistochemical features of argyrophilic grain dementia with normal cortical choline acetyltransferase levels but extensive subcortical pathology and markedly reduced dopamine. Journal of Geriatric Psychiatry and Neurology. 5: 3-13. PMID 1315137 DOI: 10.1177/002383099200500102  0.348
1992 Tago H, Maeda T, McGeer PL, Kimura H. Butyrylcholinesterase-rich neurons in rat brain demonstrated by a sensitive histochemical method. The Journal of Comparative Neurology. 325: 301-12. PMID 1281176 DOI: 10.1002/Cne.903250212  0.308
1992 Shigematsu K, McGeer PL, McGeer EG. Localization of amyloid precursor protein in selective postsynaptic densities of rat cortical neurons. Brain Research. 592: 353-7. PMID 1280522 DOI: 10.1016/0006-8993(92)91697-D  0.317
1992 McGeer PL. The pivotal role of microglia in the pathology of Alzheimer's disease Journal of Neuroimmunology. 40: 132. DOI: 10.1016/0165-5728(92)90243-E  0.366
1991 Yamada T, McGeer PL, Baimbridge KG, McGeer EG. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Research. 526: 303-7. PMID 2257487 DOI: 10.1016/0006-8993(90)91236-A  0.326
1991 Yamada T, Akiyama H, McGeer PL. Two types of spheroid bodies in the nigral neurons in Parkinson's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 18: 287-94. PMID 1913362 DOI: 10.1017/S0317167100031838  0.34
1991 Akiyama H, Yamada T, Kawamata T, McGeer PL. Association of amyloid P component with complement proteins in neurologically diseased brain tissue. Brain Research. 548: 349-52. PMID 1831062 DOI: 10.1016/0006-8993(91)91148-T  0.35
1991 McGeer PL, Walker DG, Akiyama H, Kawamata T, Guan AL, Parker CJ, Okada N, McGeer EG. Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain Research. 544: 315-9. PMID 1710165 DOI: 10.1016/0006-8993(91)90071-3  0.383
1991 Yasuhara O, Tooyama I, Akiyama H, Akiguchi I, Kimura J, McGeer PL, Hara Y, Kimura H. Reactive Astrocytes Express Acidic Fibroblast Growth Factor in Alzheimer's Disease Brain Dementia and Geriatric Cognitive Disorders. 2: 64-70. DOI: 10.1159/000107178  0.373
1990 McGeer PL, McGeer EG. Cholinergic enzyme systems in Parkinson's disease. Archives of Neurology. 25: 265-8. PMID 4157296 DOI: 10.1001/Archneur.1971.00490030091011  0.348
1990 Tooyama I, Kimura H, Akiyama H, McGeer PL. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Research. 523: 273-80. PMID 2400911 DOI: 10.1016/0006-8993(90)91496-4  0.322
1990 Akiyama H, Kaneko T, Mizuno N, McGeer PL. Distribution of phosphate-activated glutaminase in the human cerebral cortex Journal of Comparative Neurology. 297: 239-252. PMID 2196285 DOI: 10.1002/Cne.902970207  0.319
1990 Akiyama H, McGeer PL. Brain microglia constitutively express β-2 integrins Journal of Neuroimmunology. 30: 81-93. PMID 1977769 DOI: 10.1016/0165-5728(90)90055-R  0.355
1990 Zhu SG, McGeer EG, McGeer PL. gamma-Glutamyltransferase activity is unchanged in acutely quinolinate-lesioned rat neostriatum but is elevated in Huntington's disease caudate. Experimental Neurology. 107: 106-9. PMID 1967236 DOI: 10.1016/0014-4886(90)90067-3  0.331
1989 McGeer PL, Itagaki S, Akiyama H, McGeer EG. Rate of cell death in parkinsonism indicates active neuropathological process. Annals of Neurology. 24: 574-6. PMID 3239957 DOI: 10.1002/Ana.410240415  0.335
1989 McGeer PL, Itagaki S, Tago H, McGeer EG. Occurrence of HLA-DR reactive microglia in Alzheimer's disease. Annals of the New York Academy of Sciences. 540: 319-23. PMID 3061340 DOI: 10.1111/J.1749-6632.1988.Tb27086.X  0.342
1989 McGeer EG, Singh EA, McGeer PL. Peripheral-type benzodiazepine binding in Alzheimer disease. Alzheimer Disease and Associated Disorders. 2: 331-6. PMID 2848549 DOI: 10.1097/00002093-198802040-00001  0.346
1989 Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. Journal of Neuroimmunology. 24: 173-182. PMID 2808689 DOI: 10.1016/0165-5728(89)90115-X  0.346
1988 McGeer PL, McGeer EG, Itagaki S, Mizukawa K. Anatomy and pathology of the basal ganglia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 14: 363-72. PMID 2890425 DOI: 10.1017/S0317167100037756  0.362
1987 McGeer PL, Itagaki S, Tago H, McGeer EG. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neuroscience Letters. 79: 195-200. PMID 3670729 DOI: 10.1016/0304-3940(87)90696-3  0.328
1987 McGeer PL, McGeer EG, Kamo H, Wong K. Positron emission tomography and the possible origins of cytopathology in Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 501-18. PMID 3541048 DOI: 10.1016/0278-5846(86)90021-7  0.359
1987 Tago H, McGeer PL, Bruce G, Hersh LB. Distribution of choline acetyltransferase-containing neurons of the hypothalamus. Brain Research. 415: 49-62. PMID 3304532 DOI: 10.1016/0006-8993(87)90268-X  0.307
1987 McGeer EG, Singh EA, McGeer PL. Sodium-dependent glutamate binding in senile dementia. Neurobiology of Aging. 8: 219-23. PMID 2885768 DOI: 10.1016/0197-4580(87)90005-4  0.317
1987 Beach TG, Tago H, Nagai T, Kimura H, McGeer PL, McGeer EG. Perfusion-fixation of the human brain for immunohistochemistry: comparison with immersion-fixation. Journal of Neuroscience Methods. 19: 183-92. PMID 2437408 DOI: 10.1016/S0165-0270(87)80001-8  0.319
1987 McGeer EG, Singh EA, McGeer PL. γ-GLUTAMYLTRANSFERASE Alzheimer Disease & Associated Disorders. 1: 38-42. DOI: 10.1097/00002093-198701000-00005  0.333
1986 McGeer E, McGeer PL. Possible destruction of cholinoceptive neurons by overstimulation of cholinergic tracts. Canadian Journal of Physiology and Pharmacology. 64: 363-8. PMID 2871914 DOI: 10.1139/Y86-059  0.315
1983 Nagai T, McGeer PL, Peng JH, McGeer EG, Dolman CE. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls. Neuroscience Letters. 36: 195-9. PMID 6866327 DOI: 10.1016/0304-3940(83)90264-1  0.372
1982 Peng JH, McGeer PL, McGeer EG. Cross-reactivity of antibodies to chicken brain choline acetyltransferase with mammalian enzyme. Journal of Neuroimmunology. 3: 113-21. PMID 6811613 DOI: 10.1016/0165-5728(82)90045-5  0.301
1982 Wong PT, McGeer PL, Rossor M, McGeer EG. Ornithine aminotransferase in Huntington's disease. Brain Research. 231: 466-71. PMID 6459816 DOI: 10.1016/0006-8993(82)90385-7  0.349
1980 Kimura H, McGeer PL, Peng F, McGeer EG. Choline acetyltransferase-containing neurons in rodent brain demonstrated by immunohistochemistry. Science (New York, N.Y.). 208: 1057-9. PMID 6990490 DOI: 10.1126/Science.6990490  0.312
1971 McGeer PL, McGeer EG, Wada JA, Jung E. Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase. Brain Research. 32: 425-31. PMID 4944072 DOI: 10.1016/0006-8993(71)90334-9  0.317
1967 McGeer EG, Gibson S, McGeer PL. Some Characteristics Of Brain Tyrosine Hydroxylase Biochemistry and Cell Biology. 45: 53-68. DOI: 10.1007/978-1-4613-4574-9_4  0.319
1963 McGeer E, Ling G, McGeer P. Conversion of tyrosine to catecholamines by cat brain in vivo Biochemical and Biophysical Research Communications. 13: 291-296. DOI: 10.1016/0006-291X(63)90487-X  0.302
1956 Rathmann GB, Curtis AJ, Mcgeer PL, Smyth CP. Microwave absorption and molecular structure in liquids. XIII. The critical wavelengths of some aliphatic ethers and long-chain ketones The Journal of Chemical Physics. 25: 413-416. DOI: 10.1063/1.1742936  0.706
1952 Curtis AJ, McGeer PL, Rathmann GB, Smyth CP. Microwave Absorption and Molecular Structure in Liquids. VII. Effects of Viscosity and Dipole—Dipole Forces1 Journal of the American Chemical Society. 74: 644-648. DOI: 10.1021/Ja01123A018  0.414
Show low-probability matches.